Carlsmed, Inc. (CARL) stock
CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30118% above fair value
$17.74+0.39 (+2.25%)
Close on Nov 17, 2026Market cap $484.35MP/E –Yield –
Carlsmed cash
Cash and short-term investments held at the end of each period.
Carlsmed's cash was $70.24M at Jun 30, 2026. For fiscal 2025 it was $109.79M, up 173.6% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $109.79M | +173.6% |
| FY2024 | Dec 31, 2024 | $40.13M | +455.6% |
| FY2023 | Dec 31, 2023 | $7.22M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $70.24M | +109.9% |
| Q1 FY2026 | Mar 31, 2026 | $97.02M | +123.4% |
| Q4 FY2025 | Dec 31, 2025 | $109.79M | +173.6% |
| Q3 FY2025 | Sep 30, 2025 | $115.37M | +159.6% |
| Q2 FY2025 | Jun 30, 2025 | $33.47M | -12.3% |
| Q1 FY2025 | Mar 31, 2025 | $43.43M | +501.4% |
| Q4 FY2024 | Dec 31, 2024 | $40.13M | – |
| Q3 FY2024 | Sep 30, 2024 | $44.44M | – |
| Q2 FY2024 | Jun 30, 2024 | $38.15M | – |
| Q4 FY2023 | Dec 31, 2023 | $7.22M | – |
See a number that looks wrong?